3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Burkitt Lymphoma
20
Leukemia, Biphenotypic, Acute
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Recurrence
3
Leukemia
3
Neoplasm, Residual
2
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Large Granular Lymphocytic
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Down Syndrome
1
Blast Crisis
1
Interventions
Cyclophosphamide
4
fludarabine phosphate
3
ibrutinib
2
fludarabine
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Mesna
2
Bone Marrow Transplantation
2
pirtobrutinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
Surveys and Questionnaires
1
Patient Reported Outcome Measures
1
Melphalan
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphoid
×
blinatumomab
×
90 days
×
Clear all
No trials found.